Literature DB >> 21549355

Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia.

Monsheel S Sodhi1, Micah Simmons, Robert McCullumsmith, Vahram Haroutunian, James H Meador-Woodruff.   

Abstract

BACKGROUND: Impairment of glutamate neurons that relay sensory and cognitive information from the medial dorsal thalamus to the dorsolateral prefrontal cortex and other cortical regions may contribute to the pathophysiology of schizophrenia. In this study, we have assessed the cell-specific expression of glutamatergic transcripts in the medial dorsal thalamus.
METHODS: We used laser capture microdissection to harvest two populations of medial dorsal thalamic cells, one enriched with glutamatergic relay neurons and the other with gamma-aminobutyric acidergic neurons and astroglia, from postmortem brains of subjects with schizophrenia (n = 14) and a comparison group (n = 20). Quantitative polymerase chain reaction of extracted RNA was used to assay gene expression in the different cell populations.
RESULTS: The transcripts encoding the ionotropic glutamate receptor subunits NR2D, GluR3, GluR6, GluR7, and the intracellular proteins GRIP1 and SynGAP1 were significantly decreased in relay neurons but not in the mixed glial and interneuron population in schizophrenia.
CONCLUSIONS: Our data suggest that reduced ionotropic glutamatergic expression occurs selectively in neurons, which give rise to the cortical projections of the medial dorsal thalamus in schizophrenia, rather than in thalamic cells that function locally. Our findings indicate that glutamatergic innervation is dysfunctional in the circuitry between the medial dorsal thalamus and cortex.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549355      PMCID: PMC3176961          DOI: 10.1016/j.biopsych.2011.02.022

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  88 in total

1.  Immunofluorescence staining of astrocytes in vitro using antiserum to glial fibrillary acidic protein.

Authors:  D S Antanitus; B H Choi; L W Lapham
Journal:  Brain Res       Date:  1975-05-23       Impact factor: 3.252

Review 2.  Glutamate receptors and transporters in the hippocampus in schizophrenia.

Authors:  Paul J Harrison; Amanda J Law; Sharon L Eastwood
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

Review 3.  Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia.

Authors:  D C Javitt
Journal:  Hillside J Clin Psychiatry       Date:  1987

4.  Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.

Authors:  Robert E McCullumsmith; Lars V Kristiansen; Monica Beneyto; Elizabeth Scarr; Brian Dean; James H Meador-Woodruff
Journal:  Brain Res       Date:  2006-11-17       Impact factor: 3.252

5.  VGluT2 immunochemistry identifies thalamocortical terminals in layer 4 of adult and developing visual cortex.

Authors:  Marc Nahmani; Alev Erisir
Journal:  J Comp Neurol       Date:  2005-04-18       Impact factor: 3.215

6.  SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons.

Authors:  Gavin Rumbaugh; J Paige Adams; Jee H Kim; Richard L Huganir
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

7.  Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

Authors:  Jean Théberge; Yousef Al-Semaan; Peter C Williamson; Ravi S Menon; Richard W J Neufeld; Nagalingam Rajakumar; Betsy Schaefer; Maria Densmore; Dick J Drost
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

8.  Chronic phencyclidine administration reduces the expression and editing of specific glutamate receptors in rat prefrontal cortex.

Authors:  Alessandro Barbon; Fabio Fumagalli; Luca La Via; Luca Caracciolo; Giorgio Racagni; Marco Andrea Riva; Sergio Barlati
Journal:  Exp Neurol       Date:  2007-07-19       Impact factor: 5.330

9.  Multiplex preamplification of specific cDNA targets prior to gene expression analysis by TaqMan Arrays.

Authors:  Lourdes Mengual; Moisès Burset; Mercedes Marín-Aguilera; María José Ribal; Antonio Alcaraz
Journal:  BMC Res Notes       Date:  2008-06-05

10.  Calcium signaling in neurodegeneration.

Authors:  Philippe Marambaud; Ute Dreses-Werringloer; Valérie Vingtdeux
Journal:  Mol Neurodegener       Date:  2009-05-06       Impact factor: 14.195

View more
  25 in total

1.  Copy number variable microRNAs in schizophrenia and their neurodevelopmental gene targets.

Authors:  William Warnica; Daniele Merico; Gregory Costain; Simon E Alfred; John Wei; Christian R Marshall; Stephen W Scherer; Anne S Bassett
Journal:  Biol Psychiatry       Date:  2014-05-29       Impact factor: 13.382

Review 2.  Schizophrenia as a disorder of molecular pathways.

Authors:  Szatmár Horváth; Károly Mirnics
Journal:  Biol Psychiatry       Date:  2014-01-10       Impact factor: 13.382

Review 3.  The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.

Authors:  Wei Hu; Matthew L MacDonald; Daniel E Elswick; Robert A Sweet
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

4.  Xanthurenic Acid Formation from 3-Hydroxykynurenine in the Mammalian Brain: Neurochemical Characterization and Physiological Effects.

Authors:  K V Sathyasaikumar; M Tararina; H-Q Wu; S A Neale; F Weisz; T E Salt; R Schwarcz
Journal:  Neuroscience       Date:  2017-10-12       Impact factor: 3.590

5.  Update on the neurobiology of schizophrenia: a role for extracellular microdomains.

Authors:  D Shan; S Yates; R C Roberts; R E McCullumsmith
Journal:  Minerva Psichiatr       Date:  2012-09-01

Review 6.  Postmortem brain: an underutilized substrate for studying severe mental illness.

Authors:  Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-10-04       Impact factor: 7.853

7.  Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons?

Authors:  R E McCullumsmith; S M O'Donovan; J B Drummond; F S Benesh; M Simmons; R Roberts; T Lauriat; V Haroutunian; J H Meador-Woodruff
Journal:  Mol Psychiatry       Date:  2015-09-29       Impact factor: 15.992

8.  Cell-subtype-specific changes in adenosine pathways in schizophrenia.

Authors:  Sinead Marie O'Donovan; Courtney Sullivan; Rachael Koene; Emily Devine; Kathryn Hasselfeld; Cassidy Lynn Moody; Robert Erne McCullumsmith
Journal:  Neuropsychopharmacology       Date:  2018-02-26       Impact factor: 7.853

9.  Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia.

Authors:  Jennifer A Hadley; Rodolphe Nenert; Nina V Kraguljac; Mark S Bolding; David M White; Frank M Skidmore; Kristina M Visscher; Adrienne C Lahti
Journal:  Neuropsychopharmacology       Date:  2013-10-29       Impact factor: 7.853

10.  GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia.

Authors:  Kiran Sapkota; Zhihao Mao; Paul Synowicki; Dillon Lieber; Meng Liu; Tsuneya Ikezu; Vivek Gautam; Daniel T Monaghan
Journal:  J Pharmacol Exp Ther       Date:  2015-12-16       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.